0001104659-21-025193.txt : 20210218
0001104659-21-025193.hdr.sgml : 20210218
20210218160113
ACCESSION NUMBER: 0001104659-21-025193
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210217
FILED AS OF DATE: 20210218
DATE AS OF CHANGE: 20210218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40030
FILM NUMBER: 21649439
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER NAME:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Decibel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001656536
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464198709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 02215
BUSINESS PHONE: 617-370-8701
MAIL ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 02215
4
1
tm216952-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-02-17
1
0001656536
Decibel Therapeutics, Inc.
DBTX
0000872589
REGENERON PHARMACEUTICALS, INC.
REGENERON PHARMACEUTICALS, INC.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
0
1
0
Common Stock
2021-02-17
4
C
0
2097314
A
2097314
D
Series B Preferred Stock
2021-02-17
4
C
0
12500000
0
D
Common Stock
989299
0
D
Series C Preferred Stock
2021-02-17
4
C
0
14000000
0
D
Common Stock
1108015
0
D
1. The Series B Preferred Stock and Series C Preferred Stock converted into shares of common stock of Decibel Therapeutics, Inc. ("Decibel") on an approximately one-for-0.079 basis upon the closing of Decibel's initial public offering, which occurred on February 17, 2021. The Series B Preferred Stock and Series C Preferred Stock had no expiration date. The reported number of shares of underlying common stock and the conversion ratio give effect to Decibel's one-for-5.3 reverse stock split, which became effective on February 5, 2021.
/s/ Richard Gluckselig, Executive Director, Assistant General Counsel and Assistant Secretary
2021-02-18